Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Global Pricing Innovations Ltd (GPI)

Global Pricing Innovations supports price decision-making through data-driven insights and bespoke analytical solutions. GPI tools and services maximize clients’ price and value understanding and optimize pre-launch and post-launch decision making

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Genetic Digital

We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create impactful assets and strategies to drive long-term growth and positive…

View Profile

Creative and design, Digital communications, IT solutions, Marketing consultancies, Medical communications

Company Details

Global Pricing Innovations Ltd (GPI)
Park House, 110 Park Street, London, W1K 6SS, United Kingdom
+44 (0)203 8743050
Contact Global Pricing Innovations Ltd (GPI)
Website

 Latest Content from PMHub 

Joint Clinical Assessments: bureaucratic nightmare, AI opportunity, or both?

White Papers and Resources | June 28, 2024 | AMICULUM

By Manca Povsic and Andrew Dobb

Unrivalled Convenience - Perks of Virtual Medical Education

Videos and Podcasts | June 27, 2024 | Impetus Digital

Explore the unrivalled convenience of virtual collaboration in medical education with our new series, "Perks of Virtual Medical Education." Learn why this flexible, efficient mode of learning is the future...

OPEN Health and fusion announce partnership to deliver AI-powered healthcare communications

Press Releases | June 24, 2024 | OPEN Health

OPEN Health, a pre-eminent global provider of scientific communications, HEOR and market access, patient engagement, and consulting, today announced a partnership with fusion, an innovative artificial intelligence (AI) and machine...

Eyes on the horizon: six (and a half) predictions for the future of healthcare communications

White Papers and Resources | June 21, 2024 | AMICULUM

By Zoë van Helmond and Leyna Prince

Unleashing Creativity in Virtual Pharma Engagements

Videos and Podcasts | June 20, 2024 | Impetus Digital

Think outside the box with virtual engagements! Discover how creative asynchronous touchpoints can revolutionize your interactions. Explore everything from OLAs to treatment pathway profiling via a pharma-compliant virtual platform.

Genesis Research Group Announces Participation of CEO David W. Miller in New ITN Business Healthcare Program

Press Releases | June 18, 2024 | Genesis Research Group

Genesis Research Group, led by newly appointed CEO, David W. Miller, is spotlighted in June’s launch of ITN Business’ “Advancing Healthcare” program for its ‘innovate differently’ approach to supporting life...

Alice Beer of ITN Business recently interviewed David W. Miller, CEO of Genesis Research Group, on 'Advancing Healthcare'

Videos and Podcasts | June 18, 2024 | Genesis Research Group

ITN Business invited Genesis Research Group to contribute to a news style programme 'Advancing Healthcare' featuring key opinion leaders in the healthcare sector. Our CEO David W. Miller was one...

How does Genesis Research Group 'Innovate differently'?

Videos and Podcasts | June 18, 2024 | Genesis Research Group

New Genesis Research Group CEO David W. Miller explains what we mean when we say we help our life science clients to 'Innovate differently' and transform the way they engage...

Mtech Access have joined Petauri!

Press Releases | June 18, 2024 | Mtech Access – Powered by Petauri™

Mtech Access are now part of Petauri. This marks a significant and exciting milestone in our journey, and aligns with our commitment to partnering with industry to bring life-enhancing technologies...

Envision Analogue - An Introduction

Videos and Podcasts | June 18, 2024 | Genesis Research Group

Powered by primary payer market research, Envision is an online platform that provides forward-looking evaluations and comprehensive strategic direction for market access viability after an oncology product has received positive...